Latest News for: antibody
Edit
‘Flesh-eating’ fungus: Fatal infection on the rise but this new antibody treatment could change everything, ...
Hindustan Times 23 Mar 2025
Their paper, "A humanized antibody against mucormycosis targets angioinvasion and augments the host immune response," was recently accepted and published in the Science Translational Medicine journal.
Edit
Antibody-based therapy shows potential against lethal mucormycosis
Madhyamam 22 Mar 2025
An antibody-based treatment has demonstrated potential in combating the deadly fungal infection mucormycosis, which led to severe cases among Covid-19 patients.Mucormycosis is caused by fungi ...
Edit
Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies
PR Newswire 21 Mar 2025
Under the terms of the agreements, AstraZeneca will obtain the option to license two preclinical immunology programs and will nominate further targets for Harbour BioMed to discover next generation multi-specific antibodies.
Edit
BioInvent's anti TNFR2 antibody BI 1808 showcased at the 16th Annual T Cell Lymphoma Forum (BioInvent International AB)
Public Technologies 21 Mar 2025
Edit
Anti CD19 monoclonal antibody UPLIZNAⓇ for I.V. Infusion 100mg Application for additional indication of immunoglobulin G4 related disease in Japan［PDF:435.6 KB］ (Mitsubishi Tanabe Pharma Corporation)
Public Technologies 21 Mar 2025
Edit
【Mitsubishi Tanabe Pharma】Anti CD19 monoclonal antibody UPLIZNA® for I.V. Infusion 100mg Application for additional indication of immunoglobulin G4 related disease in JapanNEW (Mitsubishi Chemical Group Corporation)
Public Technologies 21 Mar 2025
Edit
Next-Gen Immunotherapy: Trispecific Antibodies Show 260x Potency Over Traditional Treatments
Nasdaq Globe Newswire 20 Mar 2025
The trispecific antibody market is rapidly advancing, with 50+ candidates in clinical trials and first approvals expected by 2028 ... offering greater potency than monoclonal and bispecific antibodies.
Edit
HYFT Technology AI Bio-Native Frameworkfor Drug Discovery (ImmunoPrecise Antibodies Ltd)
Public Technologies 20 Mar 2025
). +. HYFT Technology. AI Bio-Native Framework for Drug Discovery. Dirk Van Hyfte MD PhD. CTO and Co-founder, BioStrand (IPA). VULTR + BIOSTRAND. 2025. CONFIDENTIAL AND PROPRIETARY. 2024. Welcome . Why AI Bio-Native Matters ... 2025 ... + ... ImmunoPrecise Antibodies Ltd.
Edit
The Galveston Daily News
19 Mar 2025
Bispecific Antibody Market Opportunity & Clinical Trials Insight 2030: Bispecific Antibody Drug Sales Forecast to ...
The Galveston Daily News
19 Mar 2025
Edit
Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based ...
Nasdaq Globe Newswire 19 Mar 2025
... first-in-class antibody-based therapeutics for the treatment of cancer.
Edit
Antibody Drug Conjugates (ADCs) Contract Manufacturing Market Research Report 2025: Growth Trends and Regional Forecasts ...
Nasdaq Globe Newswire 19 Mar 2025
Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Contract ... Antibody Drug Conjugates Contract Manufacturing Market Report Highlights .
Edit
Therapeutic Antibodies, Biosimilars & RNA Therapy Sales Report - Top-Selling Biologic Drugs & Market Trends ...
Nasdaq Globe Newswire 19 Mar 2025
Covering cancer antibodies, non-TNF inflammatory mAbs, biosimilars, gene therapy, RNA-based drugs, and more, the report provides detailed sales data, growth trends, and top biologics rankings.
Edit
Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
Pharmiweb 19 Mar 2025
... potentially first-in-class antibody-based therapeutics for the treatment of cancer ... “This partnership underscores our commitment to advancing potentially first-in-class antibody-based therapeutics.
Edit
Game-changer in cancer treatment: Antibody therapy to replace invasive surgeries
Interesting Engineering 19 Mar 2025
... partnership with Roche to develop new antibody-based cancer therapies ... The company specializes in creating advanced therapies, including Bispecific Antibodies and Antibody Drug Conjugates (ADCs).
- 1
- 2
- Next page »